BerGenBio AS

BerGenBio AS (BerGenBio) is a biotechnology company engaged in providing cutting-edge research and development services to the global biotechnology and pharmaceutical industry. It is founded by researchers at the department of biomedicine, University of Bergen. BerGenBio utilizes its unique patented CellSelect RNAi technology which increases the efficiency of drug development, and thereby reduces the time to market, R&D costs and increase success rate. The company provides tailored cell lines and disease modeling systems using its cell lines and assay systems. In addition, BerGenBio offers contract research and development services to pharmaceutical and biotechnology companies. It is actively pursuing collaborations for pipeline development of novel drug targets and therapeutics, including small molecules, anti bodies and RNAi drugs. BerGenBio is headquartered in Bergen, Norway.

Street: 
Thormohlensgt 51
City: 
BERGEN
Postcode: 
5006
Federal State : 
Norway
WebSite: 
www.bergenbio.com
Fax: 
47-55-586383

Company Index Score

Current Index Score Historical Index Score
  • BerGenBio AS currently scores 50 % in the index.
  • BerGenBio AS is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • BerGenBio AS is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets